Joint Formulary & PAD

Homepage

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

Search terms include drug names, indications, brand names and keywords.

A-Z of Drugs :
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Quick Links

Please select from the links below to explore this site.

Show

Welcome to the Joint Formulary and PAD

News

Welcome to the Surrey Heartlands Joint Formulary & Prescribing Advisory Database (PAD)

Please take a moment to read the welcome article. There are a few therapeutic areas that have not yet been added to the formulary: Smoking Cessation, Vaccines, Antimalarials. These are in the process of being reviewed and will be uploaded over the next few months. For a full list of outstanding sections, please read the article by clicking the article title above. Thank you
Article published on : 07 May 2025

Frequently asked questions

Article published on : 11 Jun 2025

Levemir (insulin detemir) Penfill and FlexPen discontinuation

Levemir Penfill and FlexPen are to be discontinued. Stock likely to be exhausted by December 2026. All patients will need to be switched to an alternative insulin - see article for more information and advice.
Article published on : 11 Sep 2025

Semaglutide TABLETS - CHANGE OF STRENGTH

Semaglutide tablets (Rybelsus) are now available in new, lower strengths. Patients will need to be switched to a new strength and will require appropriate counselling to avoid the risk of incorrect dosing. The 3mg, 7mg and 14mg tablets are being phased out and being replaced by 1.5mg, 4mg and 9mg tablets. See the full article for more details and resources.
Article published on : 14 Nov 2025
Show

Latest Additions (12)